Nominations for the 2008 Award are now closed!
Winner will be announced in September 2008.
The Award and Lecture
The AACR Outstanding Investigator Award for Breast Cancer Research, funded by Susan G. Komen for the Cure, will recognize an investigator whose novel and significant work has had or may have a far-reaching impact on the etiology, detection, diagnosis, treatment, or prevention of breast cancer. Such work may involve any discipline across the continuum of biomedical research, including basic, translational, clinical, and epidemiological studies.
The recipient of this Award will receive a $10,000 honorarium and will present a 30-minute lecture at the 31st Annual San Antonio Breast Cancer Symposium. The symposium will be held December 10-14, 2008 at the Henry B. Gonzalez Convention Center in San Antonio, TX.
Eligibility
- All cancer researchers who are affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world may be nominated. Such institutions include those in academia, industry, or government.
- Candidates must be no more than 50 years of age at the time the Award is received, i.e. born on or after December 15, 1957.
- The Award will be presented to an individual investigator.
- Institutions or organizations are not eligible for the Award.
Nomination Process
Nominations for the Award must be submitted electronically to the AACR to awards@aacr.org no later than 4:00 p.m. United States Eastern Time on Monday, July 14, 2008. Paper nominations will not be accepted.
Nominations may be made by any scientist, whether an AACR member or nonmember, who is now or has been affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science.
Candidates may not nominate themselves.
Nominators are asked to maintain the confidentiality of the nomination process and to refrain from informing the candidate about the nomination.
There is no restriction on the number of candidates that may be nominated by any institution or individual.
Nomination Materials
The following materials must be sent electronically to the AACR as noted above. Preferred file formats are *.doc, *.pdf. Nominations are not considered fully submitted until the nominators receive a confirmation e-mail from the AACR; confirmations will be sent within 2 business days.
1) Letter of Recommendation. The letter of recommendation must:
- be addressed to the Selection Committee; be written in English; and not exceed 1,000 words;
- specify the AACR Award for which the candidate is being nominated; and
- describe the candidate's novel and significant work that has had or may have a far-reaching impact on the etiology, detection, diagnosis, treatment, or prevention of breast cancer; the publications supporting the work should be directly referenced within the letter.
2) Candidate's CV. The candidate's curriculum vitae in English, including a complete list of the candidate's publications.
3) Summary Statement. A statement, no more than 50 words, summarizing the candidate's research accomplishments for which he or she is being nominated.
Selection
Candidates will be considered by a Committee appointed by the President of the AACR. After careful deliberations by the Award Committee, its recommendations will be forwarded to the Executive Committee of the AACR for final consideration and decision. Selection of the Award winner will be made on the basis of the candidate's scientific accomplishments without regard to race, gender, nationality, geographic location, or religious or political views.
The recipient of the inaugural AACR Outstanding Investigator Award for Breast Cancer Research, funded by Susan G. Komen for the Cure, will be announced in Fall 2008.
Nancy G. Brinker promised her dying sister, Susan G. Komen, she would do everything in her power to end breast cancer forever. In 1982, that promise became Susan G. Komen for the Cure and launched the global breast cancer movement. Today, Komen for the Cure is the world's largest grassroots network of breast cancer survivors and activists fighting to save lives, empower people, ensure quality care for all and energize science to find the cures. For the past 25 years, Komen for the Cure has played a critical role in every major advance in the fight against breast cancer - transforming how the world talks about and treats this disease and helping to turn millions of breast cancer patients into breast cancer survivors.
Questions?
Monique P. Eversley, Program Associate
monique.eversley@aacr.org
American Association for Cancer Research
17th Floor, 615 Chestnut Street
Philadelphia, PA 19106-4404
(267) 646-0576
SPOTLIGHT
Susan G. Komen for the Cure will provide more than 30 grants to young investigators presenting research at the 31st Annual San Antonio Breast Cancer Symposium.
Scholar-in-Training Awards will be presented to postdoctoral fellows, clinical fellows, or the equivalent, who are the first author and presenter of a highly meritorious abstract accepted for presentation at the conference. Preference will be given to abstracts related to translational breast cancer research.
Minority Scholar Awards will be presented to postdoctoral fellows, clinical fellows, or the equivalent, who are the first author and presenter of a highly meritorious abstract accepted for presentation at the conference. Only the following minority groups that have been defined by the National Cancer Institute as being traditionally underrepresented in cancer and biomedical research are eligible for these Awards: African Americans, Alaskan Natives, Hispanics, Native Americans, and Native Pacific Islanders.
For application information, click here.